Document is current
Any future updates will be listed below
-
Authors
Shafabakhsh, Rana
Arianfar, Farzaneh
Vosough, Massoud
Mirzaei, Hamid Reza
Mahjoubin-Tehran, Maryam https://orcid.org/0000-0001-5719-5345
khanbabaei, Hashem
Kowsari, Hamed
Shojaie, Layla https://orcid.org/0000-0002-5020-5181
Azar, Maryam Ebadi Fard
Hamblin, Michael R.
Mirzaei, Hamed https://orcid.org/0000-0002-9399-8281
- License Information
-
More Information
Article History
Received: 22 June 2020
Revised: 6 October 2020
Accepted: 23 November 2020
First Online: 11 January 2021
Compliance with ethical standards
:
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc, Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX; Mitonix, Newark, DE. The remaining authors declare that they have no conflict of interest.
